---
title: "【New Stock IPO】【Subscription Situation】【Continuously Updated】Traditional Chinese Medicine Healthcare Service Industry Tong Ren Tang Medical Care (2667) received HKD 250 million in margin financing, with an oversubscription of 1.8 times"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/280089105.md"
description: "Tong Ren Tang Medical will conduct an initial public offering from March 20 to 25, planning to issue 110 million H shares, with an offering price ranging from HKD 7.3 to HKD 8.3, aiming to raise nearly HKD 900 million. As of March 23, it has received HKD 250 million in margin subscriptions, oversubscribed by 1.8 times. Each lot consists of 500 shares, with an entry fee of HKD 4,191.9, and it is expected to be listed for trading on March 30. China International Capital Corporation is the sponsor"
datetime: "2026-03-23T02:54:31.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/280089105.md)
  - [en](https://longbridge.com/en/news/280089105.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/280089105.md)
---

# 【New Stock IPO】【Subscription Situation】【Continuously Updated】Traditional Chinese Medicine Healthcare Service Industry Tong Ren Tang Medical Care (2667) received HKD 250 million in margin financing, with an oversubscription of 1.8 times

Tong Ren Tang Medical and Health (2667.HK), a subsidiary of Tong Ren Tang Group engaged in traditional Chinese medicine healthcare services, will conduct its IPO from March 20 to 25, planning to issue 110 million H shares, with 10% available for public offering in Hong Kong. The offering price ranges from HKD 7.3 to HKD 8.3, aiming to raise nearly HKD 900 million. As of last Friday (23rd) evening, Tong Ren Tang Medical and Health has received HKD 250 million in margin subscriptions, with the public offering amounting to HKD 89.77 million, oversubscribed by 1.8 times.

The minimum investment for Tong Ren Tang Medical and Health is 500 shares, with an entry fee of HKD 4,191.9. The company expects to be listed for trading on March 30. China International Capital Corporation is the sponsor.

## Background

Beijing Tong Ren Tang Medical and Health Investment Co., Ltd. is a strategically focused subsidiary of Tong Ren Tang on traditional Chinese medicine healthcare services in China, providing comprehensive traditional Chinese medicine healthcare services to individual clients, standardized management services to institutional clients, and various health products and other products. As of March 10, 2026, the group has established a tiered traditional Chinese medicine healthcare service network, including 12 self-owned offline medical institutions and one internet hospital, as well as 12 offline managed medical institutions. Leveraging the well-known brand "Tong Ren Tang" and high-quality pharmaceuticals, the group has accumulated and integrated a large amount of online and offline medical resources

### Related Stocks

- [600085.CN](https://longbridge.com/en/quote/600085.CN.md)
- [01666.HK](https://longbridge.com/en/quote/01666.HK.md)
- [03613.HK](https://longbridge.com/en/quote/03613.HK.md)

## Related News & Research

- [Tong Ren Tang Subsidiary Posts Lower 2025 Profit as Revenue and Margins Decline](https://longbridge.com/en/news/279954067.md)
- [TVS Venu Group to acquire up to 9.9% stake in Jana Small Finance Bank](https://longbridge.com/en/news/286764159.md)
- [Triad Wealth Partners Surpasses $2B in Assets Under Management, Driven by Advisor Growth and Community Strength](https://longbridge.com/en/news/286921733.md)
- [Assessing Automatic Data Processing's Performance Against Competitors In Professional Services Industry](https://longbridge.com/en/news/286893812.md)
- [13:41 ETUT Haslam Marks Decade in Major International Ranking's Top Five U.S. Public Schools](https://longbridge.com/en/news/286804132.md)